Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemigliptin vs Sitagliptin as Add-on to Metformin in T2DM
NCT01602003Phase 3Completed
- Sponsor
- LG Chem
- Start
- Dec 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemigliptin in type 2 diabetes mellitus (T2DM), sponsored by LG Chem. Started Dec 2009; status: completed.
02
Drugs
gemigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01602003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01602003.